What is Psychedelic Harm Reduction and Integration Therapy?

In recent years, with the relaxation of regulations around the study of psychedelic substances (MDMA, psilocybin, ketamine), more research has been completed around the safety, use, and effectiveness of these medications- both on their own and in conjunction with mental health therapy.  Clinical control trials of these medications are consistently demonstrating significant improvement in symptoms of chronic depression, PTSD, and substance use disorders.   And western science is only reaffirming what many indigenous cultures have known for a long time- that the use of psychedelic substances can be instrumental for improving awareness, insight, and a feeling of connection. 

In the United States, there are an increasing number of states where psychedelic substances, like MDMA and psilocybin, are available for clinical trial use and study, but in much of the country, these substances continue to be classified as drugs of abuse.  Ketamine is the only current psychedelic medication that is approved for use in Indiana.  Other traditional plant medicines- such as ayahuasca or iboga- are mostly found in ceremonial use and may not be widely available at all in the US, leading some people to travel to other countries to experience these healing ceremonies. 

Psychadelic Harm Reduction and Integration Therapy (PHRI) is a specific model for working with clients who are interested in or have used psychedelic substances for the intention of personal growth or mental health symptom reduction.  As a therapist, my role is to help my clients understand their intentions around psychedelic use, provide education around potential effects, assist in preparation to ensure a safe experience, and processing their experiences afterward to facilitate their growth and healing.  If you are interested in exploring psychedelic medicine and want to know more about how I can support your integration process, reach out to schedule a consultation (HERE).